Apollo HealthCo Targets Q1FY27 Breakeven During Restructuring Phase

Apollo Hospitals Enterprise Limited remained in focus after the company detailed expansion plans across hospitals, diagnostics and primary care while also highlighting improving profitability in its digital healthcare business. 

Hospital Expansion Continues Despite Margin Pressure 

Apollo Hospitals said newly launched facilities temporarily impacted margins as the company accelerated expansion across key cities.  

The company added 780 beds during the year, with nearly half already operationalised, while the rest will open gradually. New hospitals in Kolkata and Hyderabad are expected to break even within 1 year. 

Suneeta Reddy, Managing Director of Apollo Hospitals, said, “There is a strong bed addition pipeline, which will contribute to revenue growth.” Apollo also plans to add 850 more beds, including projects in Gurugram and other metro markets. 

Madhu Sasidhar, President and Chief Executive Officer of Apollo Hospitals, said, “In the next 12 to 18 months, we may add around 1,500 more beds and will cross the 10,600 mark.” 

Cloudnine Proceeds To Support Clinics And Diagnostics Expansion 

Apollo Hospitals plans to use proceeds from the Cloudnine transaction to expand its primary healthcare and diagnostics business. The company will retain a 9.9% stake in the merged entity while reinvesting proceeds into clinics, diagnostics and healthcare infrastructure. 

Suneeta Reddy said Apollo already operates over 200 clinics alongside a large diagnostics network and sees primary care as a major long-term opportunity in India. “We believe that this primary care market will include investment in diagnostics and building out the clinic network,” she said. 

Apollo has also planned capital expenditure of ₹1,500 crore during the current financial year for expansion activities. 

Apollo HealthCo Reports First Full Year Of Profitability 

Apollo HealthCo reported its first full year of profitability as growth in offline pharmacies and digital healthcare services improved earnings.  

Pharmacy margins rose to 7.7%, while losses in the digital healthcare business narrowed as the company shifted focus towards sustainable profitability instead of only GMV growth. 

Apollo HealthCo is expected to achieve cash breakeven by Q1FY27 as part of a restructuring exercise set to conclude by Q4FY27.  

Under the proposed structure, Apollo HealthCo will be demerged into Apollo Healthtech Limited, after which pharma distribution business Keimed will merge into the new entity. 

Read More: Max Healthcare Q4 FY26 Results: Revenue Rises 10% YoY to ₹2,664 Crore, Expands Capacity and Strengthens Growth Pipeline! 

Conclusion 

Apollo Hospitals is simultaneously expanding hospital capacity, restructuring its healthcare platforms and strengthening digital operations as Apollo HealthCo moves closer to breakeven and the group broadens its international patient footprint. 

Want to read stock market updates in Hindi? Angel One News gives comprehensive share market news in Hindi.  

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.  

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.